公开(公告)号：US20210145865A1

公开(公告)日：2021-05-20

申请号：US17113886

申请日：2020-12-07

Applicant: OSAKA UNIVERSITY

Inventor： Shoichi SHIMADA ,  Yoshihisa KOYAMA ,  Makoto KONDO ,  Noriyoshi USUI ,  Kazuya OHATA ,  Hidenori INOHARA ,  Hikaru KOBAYASHI ,  Yuki KOBAYASHI

IPC: A61K33/00 ,  A61P3/10 ,  A61P9/10 ,  A61P25/28 ,  A61P25/16 ,  A61P25/24 ,  A61P1/16 ,  A61P17/00 ,  A61P19/02 ,  A61P29/00 ,  A61P27/16

Abstract: An object is to provide a pharmaceutical or the like that can prevent or treat an oxidative stress-induced disease. Provided is a preventive or therapeutic agent for an oxidative stress-induced disease, pharmaceutical composition, medical device, hygienic product, food, or beverage containing silicon small particles. When the silicon small particles are orally administered or placed on a skin or a mucous membrane, the oxidative stress-induced disease can be prevented or treated. The oxidative stress-induced disease is an inflammatory disease, depression, or the like, and an excellent preventive and therapeutic effect thereon is obtained.